Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × carmustine, poliferprosan 20 drug combination × 90 days × Clear all

Sponsor

Conditions

Vasculitis, Central Nervous System 1 Stiff-Person Syndrome 1 Rasmussen subacute encephalitis 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Myasthenia Gravis 1 Lambert-Eaton Myasthenic Syndrome 1 Autoimmune Diseases of the Nervous System 1 Autoimmune Diseases 1

Interventions

venetoclax 42 Rituximab 25 obinutuzumab 22 ibrutinib 22 Cyclophosphamide 22 acalabrutinib 19 pirtobrutinib 17 fludarabine 17 Specimen Handling 11 zanubrutinib 10 fludarabine phosphate 10 Biopsy 10 Bendamustine Hydrochloride 10 Magnetic Resonance Spectroscopy 7 Whole-Body Irradiation 5 Prednisone 5 Lenalidomide 5 idelalisib 4 Vincristine 4 Mycophenolic Acid 4 Doxorubicin 4 CT-P10 4 ARQ531 4 pembrolizumab 3 Tacrolimus 3 tocilizumab 2 duvelisib 2 daratumumab 2 atezolizumab 2 Therapeutics 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡